RxDoctor Payments Data

John Knab, MD

Interventional Pain Medicine · Wilmington, NCNPI 1265437008

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,802 of the $9,160 with a category attached, or 74.3%. 18 manufacturers reported payments, led by Boston Scientific at 40.7% of the total.

$9,160in general payments, 2019–2025

Across 233 payments — averaging $39.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$4K
  • Nevro Corp.$3K
  • Abbott$1K
  • Relievant Medsystems, Inc.$358
  • Globus Medical$150
  • Comsort, Inc$100
  • plus $503 from 12 others

What the payments were for

  • Consulting fees$1,26914%
  • Travel & lodging$1,08912%
  • Food & beverage$6,80274%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,160 in reported general payments places this provider in the 75th percentile of 45 interventional pain medicine providers in North Carolina.

See all interventional pain medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$507,942
Medicare patients
541
Services billed
17,158

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fentanyl13$1,260
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen52$1,137
Morphine Sulfate ErMorphine Sulfate16$493
Gabapentin40$423
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen28$391
Oxycodone Hcl17$382
Methadone Hcl12$218
Tizanidine Hcl21$145
Methocarbamol16$76
Topiramate16$70
Meloxicam19$61
Pregabalin11$58
Tramadol Hcl14$48
Diazepam18$21

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Wilmington

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →